Treatment of HIV lipoatrophy and lipoatrophy of aging with poly-L-lactic acid: A prospective 3-year follow-up study

Journal of the American Academy of Dermatology

Volumn 59, Issue 6, 2008, Pages 923-933

  Levy, Ross M ^a   Redbord, Kelley Pagliai ^a   Hanke, C William ^a  

^a St Vincent's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; COLLAGEN; HYALURONIC ACID; POLYLACTIC ACID;

ADULT; AGED; AGING; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIPOATROPHY; MAJOR CLINICAL STUDY; MALE; PAPULE; PATIENT SATISFACTION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; AGING; CELLULOSE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; LACTIC ACID; LIPODYSTROPHY; MALE; MANNITOL; MIDDLE AGED; PATIENT SATISFACTION; POLYMERS; PROSPECTIVE STUDIES;

EID: 55949115042     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.07.027     Document Type: Article

References (16)

1. Sterling J.B., and Hanke C.W. Poly-L-lactic acid as facial filler. Skin Therapy Lett 10 (2005) 9-11
2. Leonard A.L., and Hanke C.W. A protocol for facial volume restoration with poly-L-lactic acid. J Drugs Dermatol 5 (2006) 872-877
3. Hanke C.W., and Redbord K.P. Safety and efficacy of poly-L-lactic acid in HIV lipoatrophy and lipoatrophy of aging. J Drugs Dermatol 6 (2007) 123-128
4. Werschler W.P., and Smith S.A. Mechanism of action of poly-L-lactic acid: a stimulatory dermal filler. J Drugs Dermatol 6 (2007) 418-420
5. Leonard A.L., and Hanke C.W. Surgical pearl: the use of a laboratory vortex for poly-L-lactic acid injection. J Am Acad Dermatol 55 (2006) 511-512
6. Borelli C., Kunte C., Weisenseel P., Thoma-Greber E., Korting HC., and Konz B. Deep subcutaneous application of poly-L-lactic acid as a filler for lipoatrophy in HIV-infected patients. Skin Pharmacol Physiol 18 (2005) 273-278
7. Lowe N.J., Maxwell C.A., and Patnaik R. Adverse reactions to dermal fillers: review. Dermatol Surg 31 Suppl (2005) 1626-1633
8. Ascher B., Coleman S., Alster T., Bauer U., Burgess C., Butterwick K., et al. Full scope of effect of facial lipoatrophy: a framework of disease understanding. Dermatol Surg 32 (2006) 1058-1069
9. Hamilton D.G., Gauther N., and Robertson B.F. Late-onset, recurrent facial nodules associated with injection of poly-L-lactic acid. Dermatol Surg 34 (2008) 123-126
10. Woerle B., Hanke C.W., and Sattler G. Poly-L-lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol 3 (2004) 385-389
11. Vleggaar D. Facial volumetric correction with injectable poly-L-lactic acid. Dermatol Surg 31 (2005) 1511-1518
12. Valantin M.A., Aubron-Olivier C., Ghosn J., Laglenne E., Pauchard M., Schoen H., et al. Poly-L-lactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 17 (2003) 2471-2477
13. Mest D.R., and Humble G. Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience. Dermatol Surg 32 (2006) 1336-1342
14. Vleggaar D. Soft-tissue augmentation and the role of poly-L-lactic acid. Plast Reconstr Surg 118 Suppl (2006) 46-54S
15. Burgess C.M., and Quiroga R.M. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 52 (2005) 233-239
16. Moyle G.J., Lysakova L., Brown S., Sibtain N., Healy J., Priest C., et al. A randomized open-label study of immediate versus delayed poly-L-lactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 5 (2004) 82-87